CG
FLNA

Cutler Group’s Filana Therapeutics FLNA Stock Holding History

Cutler Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$84K Buy
9,600
+3,400
+55% +$78.3K 0.03% 501
2023
Q4 		$27K Buy
6,200
+5,700
+1,140% +$120K ﹤0.01% 1800
2023
Q3 		$9K Hold
500
– – ﹤0.01% 2539
2023
Q2 		$7K Sell
500
-1,200
-71% -$28.9K ﹤0.01% 2466
2023
Q1 		$8K Sell
1,700
-11,600
-87% -$321K ﹤0.01% 2483
2022
Q4 		$107K Sell
13,300
-20,800
-61% -$748K 0.01% 1125
2022
Q3 		$156K Sell
34,100
-9,000
-21% -$243K 0.01% 1106
2022
Q2 		$444K Buy
43,100
+19,400
+82% +$490K 0.03% 579
2022
Q1 		$104K Sell
23,700
-13,100
-36% -$555K 0.01% 1678
2021
Q4 		$132K Sell
36,800
-37,500
-50% -$1.97M 0.01% 1641
2021
Q3 		$313K Buy
74,300
+24,800
+50% +$2.07M 0.01% 1064
2021
Q2 		$162K Buy
49,500
+24,500
+98% +$1.31M 0.01% 1494
2021
Q1 		$151K Buy
+25,000
New +$983K 0.01% 1461
2020
Q4 		– Sell
-1,600
Closed -$1K – 5410
2020
Q3 		$1K Buy
+1,600
New +$7.21K ﹤0.01% 4441
2016
Q4 		– Sell
-600
Closed -$6K – 7203
2016
Q3 		$6K Buy
+600
New +$9.94K ﹤0.01% 4793

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cutler Group's FLNA Position: Q1 2024 in Review

Cutler Group reduced its Filana Therapeutics (FLNA) stake by 63% in Q1 2024, selling an estimated $456K and leaving 11,700 shares worth $237K. The position accounts for 0.08% of the portfolio, ranked #251.

Cutler Group first reported a position in FLNA in Q3 2016 and has held it in 18 quarters since. The position peaked at $1.46M in Q2 2021. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Cutler Group held 11,700 shares of Filana Therapeutics worth $237K as of Q1 2024.
  • Cutler Group sold 19,777 Filana Therapeutics shares in Q1 2024, an estimated $456K.
  • Filana Therapeutics made up 0.08% of Cutler Group's portfolio in Q1 2024, its #251 holding.
  • Cutler Group first reported a position in Filana Therapeutics in Q3 2016 and has held it in 18 quarters since.
  • Cutler Group's Filana Therapeutics position peaked at $1.46M in Q2 2021.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.